These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 31165524)
1. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon. GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524 [TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. GhavamiNejad A; Lu B; Samarikhalaj M; Liu JF; Mirzaie S; Pereira S; Zhou L; Giacca A; Wu XY Drug Deliv Transl Res; 2022 Apr; 12(4):792-804. PubMed ID: 33683625 [TBL] [Abstract][Full Text] [Related]
3. "Smart" Composite Microneedle Patch Stabilizes Glucagon and Prevents Nocturnal Hypoglycemia: Experimental Studies and Molecular Dynamics Simulation. Lu B; GhavamiNejad A; Liu JF; Li J; Mirzaie S; Giacca A; Wu XY ACS Appl Mater Interfaces; 2022 May; 14(18):20576-20590. PubMed ID: 35471922 [TBL] [Abstract][Full Text] [Related]
4. Dual self-regulated delivery of insulin and glucagon by a hybrid patch. Wang Z; Wang J; Li H; Yu J; Chen G; Kahkoska AR; Wu V; Zeng Y; Wen D; Miedema JR; Buse JB; Gu Z Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29512-29517. PubMed ID: 33177238 [TBL] [Abstract][Full Text] [Related]
5. On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks. Fu Y; Liu P; Chen M; Jin T; Wu H; Hei M; Wang C; Xu Y; Qian X; Zhu W J Colloid Interface Sci; 2022 Jan; 605():582-591. PubMed ID: 34343731 [TBL] [Abstract][Full Text] [Related]
6. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900 [TBL] [Abstract][Full Text] [Related]
8. Insulin-Responsive Glucagon Delivery for Prevention of Hypoglycemia. Yu J; Zhang Y; Sun W; Kahkoska AR; Wang J; Buse JB; Gu Z Small; 2017 May; 13(19):. PubMed ID: 28318091 [TBL] [Abstract][Full Text] [Related]
9. Rapid Correction of the Hypoglycemia State in Nonhuman Primates Using a Glucagon Long-Dissolving Microneedle Patch. Yu X; Wen X; Xu J; Zhou Q; Chen Y; Qu F; He M; Chang H; Zheng C ACS Biomater Sci Eng; 2024 May; 10(5):3086-3096. PubMed ID: 38588325 [TBL] [Abstract][Full Text] [Related]
10. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs. Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622 [TBL] [Abstract][Full Text] [Related]
11. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy. Zhang Y; Wu M; Tan D; Liu Q; Xia R; Chen M; Liu Y; Xue L; Lei Y J Mater Chem B; 2021 Jan; 9(3):648-657. PubMed ID: 33306077 [TBL] [Abstract][Full Text] [Related]
12. "Smart" Matrix Microneedle Patch Made of Self-Crosslinkable and Multifunctional Polymers for Delivering Insulin On-Demand. Liu JF; GhavamiNejad A; Lu B; Mirzaie S; Samarikhalaj M; Giacca A; Wu XY Adv Sci (Weinh); 2023 Oct; 10(30):e2303665. PubMed ID: 37718654 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes. Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW; J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776 [TBL] [Abstract][Full Text] [Related]
14. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes. Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314 [TBL] [Abstract][Full Text] [Related]
15. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. La Sala L; Pontiroli AE Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984 [TBL] [Abstract][Full Text] [Related]
16. Cross-Linking-Density-Changeable Microneedle Patch Prepared from a Glucose-Responsive Hydrogel for Insulin Delivery. Chen X; Yu H; Wang L; Shen D; Li C; Zhou W ACS Biomater Sci Eng; 2021 Oct; 7(10):4870-4882. PubMed ID: 34519208 [TBL] [Abstract][Full Text] [Related]
17. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes. Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587 [TBL] [Abstract][Full Text] [Related]
18. Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia . Ranjan A Dan Med J; 2018 Feb; 65(2):. PubMed ID: 29393039 [TBL] [Abstract][Full Text] [Related]
19. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin. Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia and H Yu J; Qian C; Zhang Y; Cui Z; Zhu Y; Shen Q; Ligler FS; Buse JB; Gu Z Nano Lett; 2017 Feb; 17(2):733-739. PubMed ID: 28079384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]